Table 7 |
||||
|
Non-traditional treatment usage by seizure group. |
||||
|
Treatment |
Overall |
Controls |
Clinical Seizures |
Subclinical Seizures |
|
|
||||
|
Supplement treatments |
||||
|
|
||||
|
Vitamin B12 |
24% |
32% |
20%‡ |
26% ns,ns |
|
|
||||
|
L-Carnitine/Acetyl-L-Carnitine |
21% |
22% |
18% ns |
29% ns,ns |
|
|
||||
|
Magnesium |
20% |
26% |
17% ns |
22% ns,ns |
|
|
||||
|
Coenzyme Q10 |
14% |
16% |
12% ns |
15% ns,ns |
|
|
||||
|
Glutathione |
14% |
14% |
12% ns |
18% ns,ns |
|
|
||||
|
Dimethylglycine |
11% |
14% |
9% ns |
13% ns,ns |
|
|
||||
|
Taurine |
11% |
10% |
10% ns |
14% ns,ns |
|
|
||||
|
GABA |
9% |
12% |
8% ns |
9% ns,ns |
|
|
||||
|
5-Hydroxytryptophan |
8% |
11% |
6%ns |
9% ns,ns |
|
|
||||
|
L-Carnosine |
6% |
5% |
5% ns |
10%ns,ns |
|
|
||||
|
Drug treatments |
||||
|
|
||||
|
Chelation Therapy |
12% |
15% |
10%ns |
16% ns,ns |
|
|
||||
|
Hyperbaric Oxygen Therapy |
7% |
6% |
7% ns |
10% ns,ns |
|
|
||||
|
Dietary treatments |
||||
|
|
||||
|
Gluten Free Casein Free Diet |
31% |
41% |
25% † |
31%ns,ns |
|
|
||||
|
Specific Carbohydrate Diet |
6% |
4% |
6% ns |
8% ns,ns |
|
|
||||
|
Atkins or Modified Atkins Diet |
2% |
1% |
3% ns |
2% ns,ns |
|
|
||||
|
‡p < = 0.001; †p < = 0.0001 For each treatment listed, statistical comparisons were made between the clinical seizure group and the control group (superscript after the clinical seizure percentage), the subclinical seizure group and the control group (1st superscript after the subclinical seizure percentage) and between the clinical and subclinical seizure group (2nd superscript after the subclinical seizure percentage). There are 15 treatments and 3 comparisons for each treatments resulting in 45 comparisons. The Bonferroni correction results in an alpha of 0.05/45 = 0.0011, so we have set the alpha to p < = 0.001 to be conservative. |
||||
|
Frye et al. BMC Pediatrics 2011 11:37 doi:10.1186/1471-2431-11-37 |
||||
